报告期 | 销售毛利率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
---|---|---|---|---|---|---|---|---|
2024-09-30 | 74.41% | 12.99% | 1.61% | 26/54 | 69.26% | 我武生物 | 95.26% | 行业排名> |
2024-06-30 | 73.23% | 17.46% | 2.26% | 25/54 | 68.54% | 西藏药业 | 95.7% | 行业排名> |
2024-03-31 | 71.61% | 7.71% | 11.9% | 27/54 | 69.17% | 康华生物 | 95.85% | 行业排名> |
2023-12-31 | 64% | -2% | -2.82% | 34/54 | 68.33% | 我武生物 | 95.26% | 行业排名> |
2023-09-30 | 65.85% | 1.42% | 5.62% | 34/54 | 68.07% | 我武生物 | 95.4% | 行业排名> |
2023-06-30 | 62.35% | -7.75% | -6.22% | 33/54 | 63.32% | 华兰疫苗 | 101.02% | 行业排名> |
2023-03-31 | 66.49% | -9.96% | 1.81% | 33/54 | 69.48% | 华兰疫苗 | 100.22% | 行业排名> |
2022-12-31 | 65.3% | -5.46% | 0.58% | 32/54 | 68.27% | 我武生物 | 95.39% | 行业排名> |
2022-09-30 | 64.93% | -10.33% | -3.94% | 35/54 | 71.28% | 我武生物 | 95.63% | 行业排名> |
2022-06-30 | 67.59% | -13.41% | -8.47% | 33/54 | 69.18% | 我武生物 | 95.75% | 行业排名> |
2022-03-31 | 73.84% | -10.64% | 6.89% | 28/54 | 71.63% | 华兰疫苗 | 98.39% | 行业排名> |
2021-12-31 | 69.08% | -9.87% | -4.6% | 34/54 | 72.33% | 百奥泰 | 95.74% | 行业排名> |
2021-09-30 | 72.41% | -8.76% | -7.24% | 32/54 | 73.87% | 我武生物 | 95.89% | 行业排名> |
2021-06-30 | 78.06% | -7.36% | -5.54% | 32/54 | 73.72% | 百奥泰 | 96.33% | 行业排名> |
2021-03-31 | 82.63% | -1.51% | 7.82% | 20/54 | 73.03% | 义翘神州 | 96.83% | 行业排名> |
2020-12-31 | 76.64% | -13.2% | -3.42% | 31/54 | 71.61% | 义翘神州 | 96.88% | 行业排名> |
2020-09-30 | 79.35% | -9.92% | -5.82% | 23/54 | 73.64% | 义翘神州 | 96.56% | 行业排名> |
2020-06-30 | 84.26% | -3.02% | -4.58% | 22/54 | 88.2% | 华兰疫苗 | 707.43% | 行业排名> |
2019-12-31 | 88.3% | 165.25% | 0.23% | 12/54 | 72.44% | 我武生物 | 95.6% | 行业排名> |
2019-09-30 | 88.09% | 470.93% | 1.4% | 7/54 | 70.09% | 我武生物 | 96.43% | 行业排名> |
2019-06-30 | 86.88% | 463.06% | 3.55% | 8/54 | 69.35% | 我武生物 | 96.51% | 行业排名> |
2019-03-31 | 83.9% | 441.3% | 152.03% | 10/54 | 69.07% | 我武生物 | 96.46% | 行业排名> |
2018-12-31 | 33.29% | -63.23% | 115.75% | 36/54 | 71.54% | 我武生物 | 96.44% | 行业排名> |
2018-09-30 | 15.43% | 2% | 0% | 24/54 | 67.51% | 康辰药业 | 95.1% | 行业排名> |
2018-06-30 | 15.43% | -41.84% | -0.45% | 25/54 | 67.2% | 康辰药业 | 94.98% | 行业排名> |
2018-03-31 | 15.5% | 2% | -82.88% | 22/54 | 65.03% | 康辰药业 | 94.9% | 行业排名> |
2017-12-31 | 90.53% | 75.53% | 241.24% | 4/54 | -887.82% | 我武生物 | 93.37% | 行业排名> |
2017-06-30 | 26.53% | 100.04% | -48.56% | 23/54 | 63.83% | 我武生物 | 96.35% | 行业排名> |
2016-12-31 | 51.58% | -45.94% | 100.07% | 25/54 | 68.41% | 我武生物 | 97% | 行业排名> |
2016-06-30 | -73673.95% | -84259.85% | -77323.62% | 24/54 | -3007.12% | 我武生物 | 96.96% | 行业排名> |
2015-12-31 | 95.4% | 161.91% | 8.98% | 2/54 | 65.23% | 我武生物 | 97.16% | 行业排名> |
2015-06-30 | 87.54% | 2% | 140.32% | 4/54 | 61.38% | 欧林生物 | 99.46% | 行业排名> |